Filing Details
- Accession Number:
- 0001209191-19-055045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-04 19:32:28
- Reporting Period:
- 2019-11-01
- Accepted Time:
- 2019-11-04 19:32:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1269021 | Portola Pharmaceuticals Inc | PTLA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187333 | Hollings Renton | C/O Portola Pharmaceuticals, Inc. 270 East Grand Ave. South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-01 | 5,000 | $9.00 | 18,194 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-11-01 | 5,000 | $30.00 | 13,194 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2019-11-01 | 5,000 | $0.00 | 5,000 | $9.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,000 | 2020-04-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,826 | Indirect | Held by The Renton Family Community Property Trust |
Footnotes
- The sale reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2019.
- The option, representing a right to purchase a total of 20,000 shares, became exercisable monthly over a two year period beginning on May 29, 2010.